| Literature DB >> 31242047 |
Tsubasa Takizawa1, Tao Qin1, Andreia Lopes de Morais1, Kazutaka Sugimoto1, Joon Yong Chung2,3, Liza Morsett4, Inge Mulder1, Paul Fischer1,5, Tomoaki Suzuki1, Maryam Anzabi1, Maximilian Böhm1,5, Wen-Sheng Qu1, Takeshi Yanagisawa1, Suzanne Hickman4, Joseph El Khoury4, Michael J Whalen2,3, Andrea M Harriott1,6, David Y Chung1,6, Cenk Ayata1,6.
Abstract
Cortical spreading depolarization (CSD) induces pro-inflammatory gene expression in brain tissue. However, previous studies assessing the relationship between CSD and inflammation have used invasive methods that directly trigger inflammation. To eliminate the injury confounder, we induced CSDs non-invasively through intact skull using optogenetics in Thy1-channelrhodopsin-2 transgenic mice. We corroborated our findings by minimally invasive KCl-induced CSDs through thinned skull. Six CSDs induced over 1 h dramatically increased cortical interleukin-1β (IL-1β), chemokine (C-C motif) ligand 2 (CCL2), and tumor necrosis factor-α (TNF-α) mRNA expression peaking around 1, 2 and 4 h, respectively. Interleukin-6 (IL-6) and intercellular adhesion molecule-1 (ICAM-1) were only modestly elevated. A single CSD also increased IL-1β, CCL2, and TNF-α, and revealed an ultra-early IL-1β response within 10 min. The response was blunted in IL-1 receptor-1 knockout mice, implicating IL-1β as an upstream mediator, and suppressed by dexamethasone, but not ibuprofen. CSD did not alter systemic inflammatory indices. In summary, this is the first report of pro-inflammatory gene expression after non-invasively induced CSDs. Altogether, our data provide novel insights into the role of CSD-induced neuroinflammation in migraine headache pathogenesis and have implications for the inflammatory processes in acute brain injury where numerous CSDs occur for days.Entities:
Keywords: Cortical spreading depolarization; NSAIDs; dexamethasone; inflammation; optogenetics
Mesh:
Year: 2019 PMID: 31242047 PMCID: PMC7181092 DOI: 10.1177/0271678X19859381
Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN: 0271-678X Impact factor: 6.200